Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
09/2014
09/09/2014US8829157 Process for the synthesis of cyclic heptapeptide
09/09/2014US8828948 Method of treating a patient having an autoimmune disorder by administering BAFFR polypeptide
09/09/2014US8828727 Lentiviral vectors and uses thereof
09/09/2014US8828717 Framework residue substituted humanized COL-1 antibodies and their use
09/09/2014US8828672 PARP substrates and biomarkers
09/09/2014US8828669 Methods of screening for a compound that inhibits the interaction between BAFF and BCMA
09/09/2014US8828667 Methods and compositions relating to isocyanate conjugates
09/09/2014US8828665 Compounds and methods for use in detecting gabapentin
09/09/2014US8828422 Stabilized liquid egg material for extended shelf life
09/09/2014US8828401 Cytotoxic peptides and antibody drug conjugates thereof
09/09/2014US8828400 Antibody that binds to H-1 parvovirus
09/09/2014US8828399 Cytomegalovirus surface protein complex for use in vaccines and as a drug target
09/09/2014US8828397 Anti-PSGL-1 antibodies and methods of inducing cell death of an activated T cell
09/09/2014US8828396 Silent Fc variants of anti-CD40 antibodies
09/09/2014US8828395 Antibodies that bind tyrosyl-tRNA synthetases
09/09/2014US8828394 Methods for treating IgE-mediated disorder
09/09/2014US8828393 Methods for the therapy of inflammatory bowel disease using a type-1 interferon antagonist
09/09/2014US8828391 Method for EGFR directed combination treatment of non-small cell lung cancer
09/09/2014US8828390 Uses of NOGO-A inhibitors and related methods
09/09/2014US8828389 Methods of diagnosing ALS
09/09/2014US8828387 Antibody having anti-cancer activity
09/09/2014US8828386 Method for extending pregnancy by reducing intraventricular hemorrhaging in patients exhibiting at least one symptom of preeclampsia and eclampsia
09/09/2014US8828385 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof
09/09/2014US8828382 Heparin-binding epidermal growth factor-like growth factor binding proteins
09/09/2014US8828381 Co-administration of CG250 and IL-2 or IFN-alpha for treating cancer such as renal cell carcinomas
09/09/2014CA2655933C Polynucleotides and polypeptide sequences involved in cancer
09/09/2014CA2598879C Prostate stem cell
09/09/2014CA2576464C Methods and compositions for increasing longevity and protein yield from a cell culture
09/09/2014CA2473733C Cytokine receptor zcytor17 multimers
09/09/2014CA2400256C Compositions useful for regulating parkin gene activity
09/09/2014CA2284078C A lymphocyte surface receptor that binds caml, nucleic acids encoding the same and methods of use thereof
09/09/2014CA2258721C Chimeric heteromultimer adhesins
09/04/2014WO2014134587A1 Anti-p40 antibodies systems and methods
09/04/2014WO2014133741A1 Selective removal of a protein from a mixture of proteins using activated carbon by adjusting solution conditions
09/04/2014WO2014133316A1 Antibodies against tm4sf5 and anticancer compositions comprising the same
09/04/2014WO2014132210A1 Alpha-synuclein antibodies and uses thereof
09/04/2014WO2014131844A1 Vaccine against bovine leukemia virus
09/04/2014WO2014131715A1 Anti-mcsp antibodies
09/04/2014WO2014131714A1 Agents, kits and methods for complement factor h-related protein 1 detection
09/04/2014WO2014131712A1 Bispecific t cell activating antigen binding molecules
09/04/2014WO2014131711A1 Bispecific t cell activating antigen binding molecules
09/04/2014WO2014131694A1 Bispecific t cell activating antigen binding molecules
09/04/2014WO2014108484A3 Combination therapy of anti-her3 and anti-her2 antibodies
09/04/2014WO2014016737A9 Novel chicken monoclonal antibodies against human phosphorylated tau and uses thereof
09/04/2014WO2013184900A3 Immunogenic compositions and related methods
09/04/2014WO2013078135A3 Il-1 binding proteins
09/04/2014US20140249298 ANTI-HUMAN EQUILIBRATIVE NUCLEOSIDE TRANSPORTER 1 (hENT1) ANTIBODIES ADN METHODS OF USE THEREOF
09/04/2014US20140249297 Antibodies with modified isoelectric points
09/04/2014US20140249296 Using sortases to install click chemistry handles for protein ligation
09/04/2014US20140248666 Epitopes
09/04/2014US20140248664 Readily isolated bispecific antibodies with native immunoglobulin format
09/04/2014US20140248661 Zcytor19 polynucleotides, polypeptides, antibodies and methods of use
09/04/2014US20140248609 Gene detection assay for improving the likelihood of an effective response to an egfr antagonist cancer therapy
09/04/2014US20140248309 Dna promoters and anthrax vaccines
09/04/2014US20140248301 Method of inducing the production of protective anti-hiv-1 antibodies
09/04/2014US20140248295 Glycan-modified anti-cd4 antibodies for hiv prevention and therapy
09/04/2014US20140248294 Wnt4 and med12 for use in the diagnosis and treatment of tumor diseases
09/04/2014US20140248292 Compositions and methods for treating cancer
09/04/2014US20140248290 Inhibition of cancer metastasis
09/04/2014US20140248289 Methods and Compositions for the Treatment of Respiratory Conditions Via NKG2D Inhibition
09/04/2014US20140248287 Fc receptor binding proteins
09/04/2014US20140248286 Anti-hemagglutinin antibodies and methods of use
09/04/2014US20140248284 Methods for the detection and the treatment of cardiac remodeling
09/04/2014US20140248283 Monoclonal antibodies against her2 antigens, and uses therefor
09/04/2014US20140248282 Novel anti-ddr1 antibody having anti-tumor activity
09/04/2014US20140248281 Erythropoietic role of resident macrophages in hematopoietic organs
09/04/2014US20140248279 Use of il-23 and il-17 antiagonists to treat autoimmune ocular inflammatory disease
09/04/2014US20140248278 Anti-cd22 antigen binding molecules to treat lung cancer and prostate cancer
09/04/2014US20140248277 Multiple-variable dose regimen for treating tnfalpha-related disorders
09/04/2014US20140248276 Multiple-variable dose regimen for treating tnfalpha-related disorders
09/04/2014US20140248275 Multiple-variable dose regimen for treating tnfalpha-related disorders
09/04/2014US20140248274 Stable lyophilized pharmaceutical preparations of monoclonal or polyclonal antibodies
09/04/2014US20140248272 Recombinant proteins for use in vaccine, antibodies against said proteins, and diagnostic and therapeutic methods including the same
09/04/2014US20140248271 Novel human genes relating to respiratory diseases and obesity
09/04/2014US20140248267 Anti-cd33 antibodies and methods for treatment of acute myeloid leukemia using the same
09/04/2014US20140248266 Anti-cd40 antibody mutants
09/04/2014US20140248265 Therapeutic antibodies binding il 12rbeta1
09/04/2014US20140248261 Antibody against mutant alpha-actinin-4
09/04/2014US20140248238 Polypeptide constructs and uses thereof
09/04/2014US20140248215 Uses and compositions for treatment of psoriatic arthritis
09/03/2014EP2772501A1 Monoclonal antibody capable of specifically recognizing asparagine synthase
09/03/2014EP2771694A2 Monoclonal antibodies and methods of use
09/03/2014EP2771470A1 Transcription unit and use thereof in (yb2/0) expression vectors
09/03/2014EP2771365A1 Pulmonary hypertension
09/03/2014EP2771364A2 Production of heterodimeric proteins
09/03/2014EP2771363A1 Cd44 monoclonal antibody for the treatment of b-cell chronic lymphocytic leukemia and other hematological malignancies
09/03/2014EP2771362A1 Immunobinders directed against tnf
09/03/2014EP2771361A1 Bispecific immunobinders directed against tnf and il-17
09/03/2014EP2771360A1 Immunobinders directed against sclerostin
09/03/2014EP2771359A2 Tdp-43 specific binding molecules
09/03/2014EP2771358A1 Removal of virucidal agents in mixed mode chromatography
09/03/2014EP2771350A1 Topk peptides and vaccines including the same
09/03/2014EP2771037A2 Therapeutic agents and uses thereof
09/03/2014EP2771031A1 Humanized antibodies that recognize alpha-synuclein
09/03/2014EP2771029A1 Antibody formulations and methods
09/02/2014US8822664 Antibodies
09/02/2014US8822655 Pre-filtration adjustment of buffer solutes
09/02/2014US8822654 Mutated antithrombins, a process for preparing the same and their use as drugs
09/02/2014US8822653 Plasma kallikrein binding proteins
09/02/2014US8822652 Monoclonal antibodies that bind B7H6 and uses thereof
1 ... 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 ... 1494